Physician profile
James M Combs
NPI 1548418684
$5,809.11
in general payments reported to CMS, 2019-2025
29 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $501 · 2021: $770 · 2022: $957 · 2023: $1,011 · 2024: $946 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,870.53 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Propaten Vascular Graft, Gore Viabahn Endoprosthesis With Heparin |
| Philips North America LLC | $639.32 | 2019-2025 | Labosys |
| Medtronic, INC. | $617.88 | 2021-2025 | Endurant Iis, Venaseal, Heli-Fx Endoanchor System |
| Boston Scientific Corporation | $419.50 | 2019-2025 | Eluvia, Varithena Administration Pack, General - Vascular Intervention |
| Janssen Pharmaceuticals, INC | $410.75 | 2019-2023 | Xarelto |
| Cardiva Medical, INC. | $295.94 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
| Cook Medical LLC | $261.75 | 2019-2022 | |
| Lemaitre Vascular, INC. | $203.11 | 2019-2025 | Artegraft Vascular Graft, Lemaitre Embolectomy Catheter |
| Medtronic Vascular, INC. | $202.25 | 2019-2020 | |
| Pfizer INC. | $129.56 | 2019-2022 | |
| Tela Bio, INC. | $128.41 | 2019 | |
| Cashflow Solutions, LLC | $73.61 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kci USA, INC. | $59.52 | 2019-2020 | |
| Penumbra, INC. | $51.19 | 2025 | Penumbra System |
| Cardiovascular Systems INC. | $49.57 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $48.81 | 2019 | |
| Abbott Laboratories | $41.93 | 2019-2023 | Diamondback Peripheral |
| Becton, Dickinson and Company | $41.27 | 2025 | Arista |
| Shockwave Medical, INC | $33.39 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Veryan Medical Incorporated | $31.50 | 2021 | |
| Integra Lifesciences Corporation | $27.00 | 2022 | |
| Stryker Corporation | $26.51 | 2025 | Artix Mt |
| Humacyte Global, INC. | $26.50 | 2025 | Symvess |
| Bard Peripheral Vascular, INC. | $23.75 | 2019 | |
| Biom'Up France Sas | $23.70 | 2020 | |
| Solventum Corporation | $20.79 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Inari Medical, INC. | $17.96 | 2019 | |
| Baxter Healthcare | $16.91 | 2025 | Tisseel |
| Triad Life Sciences INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.